266. 家族性地中海熱 Familial mediterranean fever Clinical trials / Disease details

臨床試験数 : 28 / 薬物数 : 22 - (DrugBank : 5) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 59

13 trials found

diseases per page:

Showing 1 to 10 of 13 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05418686 (ClinicalTrials.gov)	July 2022	10/6/2022	Study of Colchicine Resistance in Familial Mediterranean Fever	Study Of Colchicine Resistance In Familial Mediterranean Fever	Mediterranean Fever;Colchicine Resistance	Biological: Capillary colchicinedosage in colchicine-resistant Familial Mediterranean Fever patients ...	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	12 Years	N/A	All	30	N/A	France
2	NCT05190991 (ClinicalTrials.gov)	October 5, 2021	3/11/2021	Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchi ...	An International Multicenter Open-label Clinical Study of the Safety and Efficacy of RPH-104 for Pre ...	Familial Mediterranean Fever;FMF	Biological: RPH-104	R-Pharm International, LLC	Atlant Clinical LLC;Center for Pharmaceutical Analytics LLC;Unimed Laboratories CJSC;Data Management ...	Recruiting	18 Years	80 Years	All	60	Phase 2	Armenia;Georgia;Russian Federation
3	NCT05092776 (ClinicalTrials.gov)	April 29, 2021	9/9/2021	Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects ...	International, Multicenter, Double Blind, Placebo-controlled, Randomized Clinical Study of Efficacy ...	Familial Mediterranean Fever;FMF	Biological: RPH-104;Drug: Placebo	R-Pharm International, LLC	Data Management 365;Atlant Clinical LLC;R-Pharm;Center of Pharmaceutical Analytics LLC;Unimed Labora ...	Recruiting	18 Years	N/A	All	60	Phase 2	Armenia;Georgia;Russian Federation
4	JPRN-UMIN000032557	2018/09/01	30/05/2018	An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicineinef ...	An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicineinef ...	familial Mediterranean fever	Tocilizumab	Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasak ...	NULL	Complete: follow-up complete	12years-old	Not applicable	Male and Female	24	Not selected	Japan
5	JPRN-UMIN000028010	2018/03/01	07/07/2017	Randomized, double-blind, parallel group comparison trial of Tocilizumab for colchicine-resistant fa ...	Randomized, double-blind, parallel group comparison trial of Tocilizumab for colchicine-resistant fa ...	familial Mediterranean fever	Tocilizumab Placebo	Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasak ...	NULL	Complete: follow-up complete	12years-old	Not applicable	Male and Female	24	Not selected	Japan
6	NCT02021084 (ClinicalTrials.gov)	December 2013	29/10/2013	The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colch ...		Familial Mediterranean Fever (FMF )	Dietary Supplement: probiotic;Dietary Supplement: Placebo	Rambam Health Care Campus	NULL	Withdrawn	5 Years	18 Years	Both	0	N/A	NULL
7	NCT01705756 (ClinicalTrials.gov)	November 2012	27/9/2012	Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever	A Randomized Placebo-Controlled Study of the Efficacy and Safety of Kineret (Anakinra), in Adult Pat ...	Familial Mediterranean Fever	Drug: Kineret	Sheba Medical Center	NULL	Completed	18 Years	65 Years	All	25	Phase 3	Israel
8	NCT02602028 (ClinicalTrials.gov)	April 2011	5/11/2015	The Comparison of the Efficacy of Once and Twice Daily ColchicineDosage in Pediatric Patients With F ...	The Comparison of the Efficacy of Once and Twice Daily ColchicineDosage in Pediatric Patients With F ...	Familial Mediterranean Fever	Drug: colchicine	Gulhane Military Medical Academy	NULL	Completed	5 Years	16 Years	Both	79	Phase 4	Turkey
9	NCT01148797 (ClinicalTrials.gov)	December 2010	21/6/2010	Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With ColchicineIntolerant or C ...	A 6 Month Phase 2, Multi-Center, Open-label, Single Arm Study to Evaluate the Safety and Efficacy of ...	Colchicine Resistant/Intolerant Familial Mediterranean Fever	Drug: Canakinumab	Novartis Pharmaceuticals	NULL	Completed	4 Years	20 Years	Both	15	Phase 2	Israel
10	NCT01075906 (ClinicalTrials.gov)	August 2010	24/2/2010	Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients	An Open-label, Parallel-group, Multiple-Dose, Pharmacokinetic and Safety Study of ColchicinePediatri ...	Familial Mediterranean Fever	Drug: colchicine sprinkle capsules	Mutual Pharmaceutical Company, Inc.	NULL	Completed	2 Years	65 Years	Both	75	Phase 1	United States;Armenia;Israel;Turkey

First Previous1 2Next Last